BrainsWay Ltd.

BRSYF ·Healthcare, Medical Devices, Israel
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $69.3M $10.5M $47.6M $16.9M $17.0M $21.7M $9.0M
Accounts Receivable $4.6M $3.8M $4.8M $6.3M $5.6M $5.5M $2.9M
Inventory $4.4M $3.7M $3.8M — — — —
Total Current Assets $79.7M $55.5M $58.1M $65.4M $24.3M $28.8M $13.5M
Property, Plant & Equipment — — — — — — —
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — —
Total Assets $94.3M $63.0M $64.5M $75.7M $34.0M $38.7M $23.6M
Liabilities
Accounts Payable $5.9M $5.3M $4.5M $4.8M $781.0K $1.3M $2.2M
Total Current Liabilities $15.3M $9.8M $8.1M $9.1M $6.8M $6.7M $8.3M
Long-Term Debt — — — — — — $2.1M
Total Liabilities $32.0M $21.4M $19.1M $18.4M $14.4M $14.5M $16.7M
Stockholders' Equity
Retained Earnings $-98.4M $-101.3M $-97.1M $-83.8M $-77.3M $-71.9M $-61.6M
Total Stockholders' Equity $62.3M $41.6M $45.4M $57.3M $19.6M $24.2M $7.0M